Investing.com - BeiGene reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
BeiGene announced earnings per share of $-4.46 on revenue of $192.5M. Analysts polled by Investing.com anticipated EPS of $-4.7 on revenue of $186.92M.
BeiGene shares are up 42.76% from the beginning of the year and are trading at $368.89 , down-from-52-week-high.They are outperforming the Nasdaq which is up 23.68% from the start of the year.
BeiGene follows other major Healthcare sector earnings this month
BeiGene's report follows an earnings beat by J&J on Tuesday, October 19, 2021, who reported EPS of $2.6 on revenue of $23.34B, compared to forecasts EPS of $2.35 on revenue of $23.64B.
Novo Nordisk ADR had beat expectations on Wednesday with third quarter EPS of $0.8209 on revenue of $5.55B, compared to forecast for EPS of $0.7768 on revenue of $5.4B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar